Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

S1900A - A Phase II Study of Rucaparib in Patients with Genomic LOH High And/Or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study) (IRB 239475)


Collapse Overview 
Collapse sponsor award id
S1900A


Collapse Biography 

Collapse Time 
Collapse start date
2019-07-03